1 Wall Street Analyst Thinks Pfizer Stock Is Going to $45. Is It a Buy Around $26?

Per Cantor Fitzgerald analyst Louise Chen's calculations published March 4, 's (NYSE: PFE) stock is going to climb by around 75% to reach or surpass $45 over the coming quarters. Chen's hypothesis for the biopharma is likely linked to its ongoing pivot away from its coronavirus medicines like Paxlovid and Comirnaty, and toward the revenue sources of the future, which management has designated as cancer therapeutics.

But is Pfizer a buy today, with a price tag around $26, and with its new oncology pipeline just starting to gear up?

There is reason to believe that this company is worth buying on the basis of its strategic plan to become a leader in cancer medicine.

Source Fool.com

Pfizer Inc. Aktie

Pfizer Inc. muss heute Verluste wegstecken. Die Aktie notiert im Vergleich zu gestern um -2,38 % tiefer.
Die Community bevorzugt Pfizer Inc., mit deutlich mehr Buy- (29) als Sell-Einschätzungen (4).
Ein Kursziel von 41 € für Pfizer Inc. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 27.74 € bedeuten.

Like: 0

PFE

Teilen